Congratulations to MiRXES Pte Ltd on winning the Scientist-Entrepreneur Award during the A*STAR Workplan Seminar 2017!
Led by Associate Professor Too Heng-Phon, Dr Zhou Lihan and Dr Zou Ruiyang, MiRXES was a BTI spin-off that advances miRNA technologies to create novel clinical diagnostics tests. They were able to commercialise their miRNA-based products and services globally after just 1 year. Partnering with A*STAR, local and overseas clinical institutions, MiRXES continues to develop new miRNA disease biomarkers in biofluids and tissues for diagnostic applications. To date, MiRXES has developed 3 novel blood-based cancer screening tests, for lung, breast and gastric cancer, which are in the late clinical validation stage. Once they pass through regulatory approval, these tests will be commercialized from 2018 onwards.
MiRXES receiving the Scientist-Entrepreneur Award from Chairman of A*STAR, Mr Lim Chuan Poh
From left: Dr Zhou Lihan, Mr Lim Chuan Poh, A/Prof Too Heng-Phon and Dr Zou Ruiyang
The driving force behind MiRXES
From left: Dr Zhou Lihan, Dr Zou Ruiyang and A/Prof Too Heng-Phon